PARTNER PROFILE

Institute for Health Data Science, Lanzhou University | China

Accelerating the translation of evidence to practice in China.

 

Overview

Learn more about about the Institute for Health Data Science team and how PEERSS supports their work.

Team members

Meet the experts that make up the PEERSS team in China.

Research

See the most recent research and resources from the Institute for Health Data Science.

Connect

Connect directly with the China team.

Partner team overview

Lanzhou University Institute of Health Data Science logo

The Institute of Health Data Science at Lanzhou University was established in January 2020 and aims to accelerate the translation of evidence to practice in China.

Under the PEERSS partnership, the Institute of Health Data Science has worked to make evidence more accessible and decisions more collaborative in China.

With PEERSS funding and support, the Institute has worked to:

Disseminate social and health-related Chinese COVID-19 literature and share the Chinese experience with other countries and organizations.

Establish a COVID-19 Chinese evidence sharing platform which is accessible to researchers and decision-makers around the world.

Provide Chinese evidence and relevant policies to support other PEERSS partner teams.

Gain the trust of key decision-makers and stakeholders in the evidence-informed policymaking space.

Moving forward, partners from China will continue to promote evidence-informed policymaking by:

Conducting methodological research on the evidence-based social science ecosystem.

Holding stakeholder dialogues and workshops with key actors to promote international collaboration.

Conducting a rapid synthesis and developing a policy brief that is informed by that synthesis.

Meet the experts from China.

Role
Team Lead
Areas of Expertise
Clinical practice guidelines; Reporting guidelines
Country
China
Role
Researcher
Areas of Expertise
Statistics; Public management
Country
China
Role
Coordinator, Researcher
Areas of Expertise
Evidence-based social science
Country
China
Role
Researcher
Areas of Expertise
Evidence brief for policy; Health policy
Country
China
Role
Researcher
Areas of Expertise
Health Policy, Evidence-informed policymaking; Health system guidance
Country
China

Publications, policy briefs and other resources from the Institute for Health Data Science

PEERSS Site Icon

Issue brief on Treatment for COVID-19 Pandemic

The world is now desperate to find ways to slow the spread of the novel coronavirus and to find effective treatments. To date, there are more than 200 clinical trials of COVID-19 treatments or vaccines that are either ongoing or recruiting patients. New ones are being added every day. The drugs being tested range from repurposed flu treatments to failed ebola drugs, to malaria treatments that were first developed decades ago.
Language

English

Year Published

2020

Type of Resource

Issue Brief

Clinical Practice Guidelines Registry: Toward Reducing Duplication, Improving Collaboration, and Increasing Transparency

Clinical trials, systematic reviews (SRs), and trustworthy clinical practice guidelines (CPGs) are central to evidence ecosystems and evidence-based health care. Efficient and transparent measures should be in place to share information about any planned work. Prospective registration provides researchers with an open platform to post protocols and record the progress of studies. Prior registration of clinical trials and SRs has brought an opportunity to improve the transparency in methods and objectives, reduce unnecessary duplication and potential biases, and provide a more reliable evidence basis for CPGs (1–3).
Language

English

Year Published

2021

Type of Resource

Guidelines

The reporting checklist for public versions of guidelines: RIGHT-PVG

Public or patient versions of guidelines (PVGs) are derivative documents that “translate” recommendations and their rationale from clinical guidelines for health professionals into a more easily understandable and usable format for patients and the public. PVGs from different groups and organizations vary considerably in terms of quality of their reporting. In order to address this issue, we aimed to develop a reporting checklist for developers of PVGs and other potential users.
Language

English

Year Published

2021

Type of Resource

Checklist

Coronavirus disease (COVID-19): a scoping review

A new type of coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) that began in Wuhan, China in late 2019 has spread across the world since then. The virus has caused an outbreak of viral pneumonia, which has been named Coronavirus disease (COVID-19). As of 24:00 on 6 February 2020, over 31,000 cases and 636 deaths had been confirmed in China [1]. Furthermore, more than 1,770,000 cases had been diagnosed in 213 countries, areas or territories as at 13 April 2020 [2]. On 23 January 2020, Chinese authorities imposed a lockdown of Wuhan [3]. On 30 January 2020, the World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern (PHEIC) [4] and on 11 March 2020, a pandemic [5].
Language

English

Year Published

2020

Type of Resource

Scoping Review

Rapid advice guidelines for management of children with COVID-19

An infectious disease, caused by a novel coronavirus, emerged in Wuhan City, China. The disease was later named coronavirus disease 2019 (COVID-19) and the virus causing it was named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid spread of COVID-19 worldwide has brought great challenges to local and global public health security and health systems. On March 12, 2020, the World Health Organization (WHO) declared the coronavirus outbreak a global pandemic and raised the risk of a global SARS-CoV-2 outbreak to “very high” (1-6).
Language

English

Year Published

2020

Type of Resource

Guidelines

Have a question about the research from China?

Use the contact form below to submit a message to the PEERSS team or reach out via email.

china@peerss.org

PEERSS PARTNERS

Explore the World of Evidence

tooltip text
\
tooltip text

Brazil

\
tooltip text

Cameroon

\
tooltip text

China

\
tooltip text

Ethiopia

\
tooltip text

Nigeria

\
tooltip text

Burkina Faso

\
tooltip text

Trinidad and Tobago

\
tooltip text

United Kingdom

\
tooltip text

Chile

\
tooltip text

Colombia

\
tooltip text

Lebanon

\
tooltip text

South Africa

\
tooltip text

Uganda

en_USEnglish